NL-OMON36120已完成不适用
A PHASE I, OPEN-LABEL, FIXED-SEQUENCE, THREE-PERIOD CROSSOVER TRIAL TO EVALUATE THE PHARMACOKINETICS OF TWO DIFFERENT TABLET FORMULATIONS OF BCI 952 COMPARED TO THE OVER-ENCAPSULATED BCI-952 PRODUCT COMPONENTS IN HEALTHY MALE SUBJECTS - BCI-952 three-period crossover bioequivalence study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male volunteer
- •Age : 18 * 40 years, inclusive
- •Body mass index (BMI) : 18-30 kg/m2, inclusive
- •non-smoking or smoking less then or equal to 5 cigarettes/day
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of the study. In case of donating any blood or significant loss of blood within 60 days of the start of drug dosing.
研究者
相似试验
已完成
1 期
Phase 1, Open-Label, Randomized, Single Dose, Crossover Interaction Study, in Healthy Male Subjects to Investigate Drug-Drug Interaction After Co-Administration of DS-5565 and MetformiCTRI/2014/01/004309Daiichi Sankyo Development Limited15
已完成
不适用
A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD STUDY IN HEALTHY ADULT MALE PARTICIPANTS TO ASSESS THE MASS BALANCE, ABSOLUTE BIOAVAILABILITY, FRACTION ABSORBED, AND PHARMACOKINETICS OF [14C]PF-06882961diabetes10018424NL-OMON49480Pfizer, Inc.6
已完成
1 期
A Phase 1, Open-label, Multi-Period, Single Sequence Study to Evaluate the Relative Bioavailability, Performance, and Safety of Two Solid Oral Doses (Paltusotine Tablets) in Healthy VolunteersMetabolic and Endocrine - Other endocrine disordersAcromegalyACTRN12622000704796Crinetics Australia Pty Ltd18
已完成
不适用
An randomly assigned, two-treatment, balanced, single dose study to evaluate the Pharmacokinetics and Pharmacodynamics of Intravenous Injection of REPOITIN and Human Serum Albumin - Free REPOITIN Injection of Serum Institute compared to licensed EPO injection injection in healthy adult subjectsCTRI/2015/11/006383Serum Institute of India Ltd66
已完成
不适用
An randomly assigned, two-treatment, balanced, single dose study to evaluate the Pharmacokinetics and Pharmacodynamics of subcutaneous Injection of REPOITIN and Human Serum Albumin - Free REPOITIN Injection of Serum Institute compared to licensed EPO injection injection in healthy adult subjectsCTRI/2015/04/005670Serum Institute of India Ltd48